Panacea Life Sciences Stock Performance
| PLSH Stock | USD 0.05 0.01 9.09% |
Panacea Life holds a performance score of 6 on a scale of zero to a hundred. The company holds a Beta of 9.37, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Panacea Life will likely underperform. Use Panacea Life maximum drawdown and the relationship between the expected short fall and period momentum indicator , to analyze future returns on Panacea Life.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Panacea Life Sciences are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly fragile basic indicators, Panacea Life demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 25.1 K | |
| Total Cashflows From Investing Activities | 522.5 K |
Panacea |
Panacea Life Relative Risk vs. Return Landscape
If you would invest 5.70 in Panacea Life Sciences on September 27, 2025 and sell it today you would lose (0.70) from holding Panacea Life Sciences or give up 12.28% of portfolio value over 90 days. Panacea Life Sciences is currently generating 1.7277% in daily expected returns and assumes 22.5545% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Panacea, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Panacea Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Panacea Life's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Panacea Life Sciences, and traders can use it to determine the average amount a Panacea Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0766
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | PLSH | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Panacea Life is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Panacea Life by adding it to a well-diversified portfolio.
Panacea Life Fundamentals Growth
Panacea OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Panacea Life, and Panacea Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Panacea OTC Stock performance.
| Return On Equity | -2.4 | |||
| Return On Asset | -0.18 | |||
| Operating Margin | (3.30) % | |||
| Current Valuation | 18.03 M | |||
| Shares Outstanding | 14.97 M | |||
| Price To Book | 0.46 X | |||
| Price To Sales | 0.55 X | |||
| Revenue | 2.06 M | |||
| EBITDA | (2.71 M) | |||
| Cash And Equivalents | 2.6 M | |||
| Cash Per Share | 0.17 X | |||
| Total Debt | 3.26 M | |||
| Debt To Equity | 7.61 % | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (3.92 M) | |||
| Earnings Per Share | (0.46) X | |||
| Total Asset | 23.78 M | |||
About Panacea Life Performance
By evaluating Panacea Life's fundamental ratios, stakeholders can gain valuable insights into Panacea Life's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Panacea Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Panacea Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Panacea Life Sciences Holdings, Inc., a seed to sale cannabinoid and nutraceutical manufacturer and research company, develops and produces natural pharmaceutical alternatives for consumers and pets. The company was incorporated in 2008 and is headquartered in Greenwood Village, Colorado. Panacea Life operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 29 people.Things to note about Panacea Life Sciences performance evaluation
Checking the ongoing alerts about Panacea Life for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Panacea Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Panacea Life is way too risky over 90 days horizon | |
| Panacea Life has some characteristics of a very speculative penny stock | |
| Panacea Life appears to be risky and price may revert if volatility continues | |
| Panacea Life has high likelihood to experience some financial distress in the next 2 years | |
| Panacea Life Sciences currently holds 3.26 M in liabilities with Debt to Equity (D/E) ratio of 7.61, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Panacea Life Sciences has a current ratio of 0.61, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Panacea Life until it has trouble settling it off, either with new capital or with free cash flow. So, Panacea Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Panacea Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Panacea to invest in growth at high rates of return. When we think about Panacea Life's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 2.06 M. Net Loss for the year was (4.78 M) with loss before overhead, payroll, taxes, and interest of (4.42 M). | |
| Panacea Life Sciences currently holds about 2.6 M in cash with (3.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 63.0% of Panacea Life outstanding shares are owned by corporate insiders |
- Analyzing Panacea Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Panacea Life's stock is overvalued or undervalued compared to its peers.
- Examining Panacea Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Panacea Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Panacea Life's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Panacea Life's otc stock. These opinions can provide insight into Panacea Life's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Panacea OTC Stock analysis
When running Panacea Life's price analysis, check to measure Panacea Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Panacea Life is operating at the current time. Most of Panacea Life's value examination focuses on studying past and present price action to predict the probability of Panacea Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Panacea Life's price. Additionally, you may evaluate how the addition of Panacea Life to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |